Monographie - N-acetylcysteine - Stabilis 4.0

Viimane versioon :
08/05/2024

Mitmesugune

N-acetylcysteine

Aerosool

Silmatilgad

Süsteravim

Suukaudne lahus

Stabiilsust ravimpreparaadid

Stabiilsust mõjutavad tegurid

Stabiilsust mõjutavad faktorid

Sobimatus

Viited

Pdf

Keemiline struktuur

Aerosool

Viited

Aerosool

Viited : N-acetylcysteine

	Tüüp	Avaldamine
549	Ajaleht	Owsley HD, Rusho WJ. Compatibility of common respiratory therapy drug combinations. Int J Pharm Compound 1997 ; 1: 121-122.
2648	Ajaleht	Rieutord A, Arnaud P, Dauphin JF, Brion F. Stability and compatibility of an aerosol mixture including N-acetylcysteine, netilmicin and betamethasone Int J Pharm 1999 ; 190, 1: 103-107.
2787	Ajaleht	Lee TY, Chen CM, Lee CN, Chaing YC. Compatibility and osmolality of inhaled N-acetylcysteine nebulizing solution with fenoterol and ipratropium. Am J Health-Syst Pharm 2005 ; 62, 8: 828-833.
2803	Ajaleht	Bonasia PJ, McVicar WK, Williams B, Ong S. Chemical and physical compatibility of levalbuterol inhalation solution concentrate mixed with budesonide, ipratropium bromide, cromolyn sodium or acetylcysteine sodium. Respiratory Care 2008 ; 683, 12: 1716-1722.
3019	Ajaleht	Bonasia P, Cook C, Cheng Y et al. Compatibility of arformoterol tartrate inhalation solution with three nebulized drugs. Curr Med Res Opin 2007 ; 23: 2477-2483.
3498	Ajaleht	Akapo S, Gupta J, martinez E, Mccrea C, Ye L, Roach M Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions. Ann Pharmacotherapy 2008 ; 42, 10: 1416-1424.

Mentions Légales